[
  {
    "ts": null,
    "headline": "BD Names Shawn Bevec as Senior Vice President of Investor Relations",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Shawn Bevec has been named senior vice president of investor relations, effective Jan. 20.",
    "url": "https://finnhub.io/api/news?id=52e9c57594723c3ed3f0bf56dfb90aff81b064305079e54bbb1fad3d52f1d9fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768391400,
      "headline": "BD Names Shawn Bevec as Senior Vice President of Investor Relations",
      "id": 138110536,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Shawn Bevec has been named senior vice president of investor relations, effective Jan. 20.",
      "url": "https://finnhub.io/api/news?id=52e9c57594723c3ed3f0bf56dfb90aff81b064305079e54bbb1fad3d52f1d9fa"
    }
  },
  {
    "ts": null,
    "headline": "BD invests $110m to expand US prefillable syringe production",
    "summary": "BD will introduce Neopak Glass Prefillable Syringe manufacturing at its facility in Columbus, Nebraska.",
    "url": "https://finnhub.io/api/news?id=35049bc77592496a2469badfa5ba093b916c0e7095a7b8017403dcb10d4d275e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768388450,
      "headline": "BD invests $110m to expand US prefillable syringe production",
      "id": 138110537,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD will introduce Neopak Glass Prefillable Syringe manufacturing at its facility in Columbus, Nebraska.",
      "url": "https://finnhub.io/api/news?id=35049bc77592496a2469badfa5ba093b916c0e7095a7b8017403dcb10d4d275e"
    }
  },
  {
    "ts": null,
    "headline": "Is Becton Dickinson (BDX) Pricing Reflect Its Recent Multi‑Year Share Price Declines",
    "summary": "If you are wondering whether Becton Dickinson's current share price lines up with its underlying worth, you are not alone. This article looks at what the market might be pricing in. The stock recently closed at US$201.52, with returns of a 1.9% decline over 7 days, 0.3% over 30 days, 3.4% year to date, a 12.7% decline over 1 year and a 17.0% decline over 3 years. Together, these figures give a mixed picture of how the market has been reassessing the shares. Recent news around Becton...",
    "url": "https://finnhub.io/api/news?id=bf185422e949e4802911d76685d281a761dbfc8fd0e504704651e56beecb6e50",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768360883,
      "headline": "Is Becton Dickinson (BDX) Pricing Reflect Its Recent Multi‑Year Share Price Declines",
      "id": 138094456,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "If you are wondering whether Becton Dickinson's current share price lines up with its underlying worth, you are not alone. This article looks at what the market might be pricing in. The stock recently closed at US$201.52, with returns of a 1.9% decline over 7 days, 0.3% over 30 days, 3.4% year to date, a 12.7% decline over 1 year and a 17.0% decline over 3 years. Together, these figures give a mixed picture of how the market has been reassessing the shares. Recent news around Becton...",
      "url": "https://finnhub.io/api/news?id=bf185422e949e4802911d76685d281a761dbfc8fd0e504704651e56beecb6e50"
    }
  },
  {
    "ts": null,
    "headline": "Assessing Becton Dickinson (BDX) Valuation After Recent Share Moves And Business Separation Plans",
    "summary": "Becton Dickinson (BDX) has been drawing attention after recent share performance that includes a small daily decline and mixed moves over the past week, month and past three months, prompting investors to reassess the medical supplier. See our latest analysis for Becton Dickinson. At a share price of $201.52, Becton Dickinson’s recent 7.9% 90 day share price return contrasts with a 12.7% decline in 1 year total shareholder return. This suggests shorter term momentum while longer term returns...",
    "url": "https://finnhub.io/api/news?id=ffb711a87777fe4d94065a643ef770a726354a20e87543542f593d519dfc1b21",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768350796,
      "headline": "Assessing Becton Dickinson (BDX) Valuation After Recent Share Moves And Business Separation Plans",
      "id": 138094457,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Becton Dickinson (BDX) has been drawing attention after recent share performance that includes a small daily decline and mixed moves over the past week, month and past three months, prompting investors to reassess the medical supplier. See our latest analysis for Becton Dickinson. At a share price of $201.52, Becton Dickinson’s recent 7.9% 90 day share price return contrasts with a 12.7% decline in 1 year total shareholder return. This suggests shorter term momentum while longer term returns...",
      "url": "https://finnhub.io/api/news?id=ffb711a87777fe4d94065a643ef770a726354a20e87543542f593d519dfc1b21"
    }
  }
]